Reeves Wiedeman

3.91203 learners

From a utopian Israeli kibbutz to the heights of Silicon Valley hype, Billion Dollar Loser chronicles the wild rise and spectacular collapse of WeWork, the coworking giant that promised to redefine modern work. Founded by Adam Neumann, whose childhood in a socialist collective shaped his vision of a "capitalist kibbutz," WeWork exploded by selling flexible office space wrapped in a community-focused brand. Backed by SoftBank’s $44 billion investment, Neumann embarked on a reckless global expansion, diversifying into unproven ventures like WeLive shared housing and WeGrow a luxury "entrepreneurial school." But his cult of personality, lavish spending, and questionable corporate governance—including self-dealing and super-voting control—exposed fatal cracks. When WeWork’s 2019 IPO filing laid bare its $2 billion annual loss and founder excesses, investor confidence crumbled. Neumann was ousted, the company’s valuation crashed from $47 billion to $8 billion, and WeWork was forced to scale back to its core office rental roots. This gripping tale is a cautionary lesson in startup hubris, capital bubbles, and the perils of prioritizing vision over financial reality.

John Carreyrou

4.1935 learners

Bad Blood by John Carreyrou is the explosive true story of Theranos, the Silicon Valley biotech startup that promised to revolutionize blood testing with just a single drop of finger-pricked blood. Founded by Elizabeth Holmes, a charismatic Stanford dropout who modeled herself after Steve Jobs, Theranos soared to a $9 billion valuation, attracting A-list investors and a star-studded board of former politicians and business leaders. But behind the sleek branding and bold vision lay a massive fraud: the company’s revolutionary technology never worked. Carreyrou, the Wall Street Journal reporter who broke the story, exposes how Holmes and her partner Sunny Balwani lied to investors, manipulated test results, pressured employees into silence, and exploited regulatory loopholes to keep the scam alive. The book uncovers the toxic corporate culture, Silicon Valley’s obsession with 'unicorn' startups, and the failures of oversight that allowed the deception to grow unchecked, culminating in Holmes’ ban from the medical industry and the collapse of Theranos. A gripping tale of ambition, deception, and the high cost of prioritizing hype over science.